Get the Stockscreener App
2.70
8.47%
-0.25
After Hours:
2.63
-0.07
-2.59%
Intensity Therapeutics Inc Stock (INTS) Forecast
The Intensity Therapeutics Inc (INTS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.9942, representing a +47.93% increase from the current price of $2.70. The highest analyst price target is $4.9642, and the lowest is $3.0242.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INTS Price Target
Average 4.6616
(+72.65% Upside)
Is Intensity Therapeutics Inc (INTS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 30.57 | Neutral |
| STOCH(9,6) | 43.08 | Neutral |
| STOCHRSI(14) | 57.10 | Neutral |
| MACD(12,26) | -0.1419 | Sell |
| ADX(14) | 44.52 | Sell |
| William %R | -77.78 | Neutral |
| CCI(14) | -235.25 | Sell |
Buy: 0
Sell: 3
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.1105
Sell
|
3.0459
Sell
|
| MA20 |
3.1564
Sell
|
3.1548
Sell
|
| MA50 |
3.4594
Sell
|
3.4482
Sell
|
| MA100 |
4.001
Sell
|
3.7908
Sell
|
| MA200 |
4.2171
Sell
|
4.0767
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, INTS could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 13 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on INTS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 30.57 indicates that INTS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 43.08 indicates that INTS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 57.1 indicates that INTS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 44.52 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -235.25 indicates that INTS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term INTS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Intensity Therapeutics Inc financial reports and earnings history, Intensity Therapeutics Inc (INTS) stock could reach $2.7967 by 2030, $14.48 by 2040 and $29.55 by 2050. See the projected annual prices until 2050 of the Intensity Therapeutics Inc stock below:
- Intensity Therapeutics Inc (INTS) is expected to reach an average price of $12.74 in 2035, with a high prediction of $12.22 and a low estimate of $8.9331. This indicates an $371.85% rise from the last recorded price of $2.70.
- Intensity Therapeutics Inc (INTS) stock is projected to chart a bullish course in 2040, with an average price target of $16.11, representing an $496.54% surge from its current level. The forecast ranges from a conservative $14.85 to a sky-high $14.48.
- Our analysts predict Intensity Therapeutics Inc (INTS) to jump 950.18% by 2045, soaring from $20.80 to an average price of $28.35, potentially reaching $27.62. While $20.80 is the low estimate, the potential upside is significant.
- Intensity Therapeutics Inc (INTS) stock is expected to climb by 2050, reaching an average of $30.52, a $1,031% jump from its current level. However, a wide range of estimates exists, with high and low targets of $29.55 and $28.53, respectively, highlighting the market's uncertainty.
Intensity Therapeutics Inc Stock (INTS) Year by Year Forecast
Intensity Therapeutics Inc Stock (INTS) Price Forecast for 2024
Our forecast for INTS stock price in 2024 now indicates an average price target of $5.6307 with a high forecast of $10.36 and a low forecast of $0.9018. The average prediction reflects an increase of +108.54% from the last recorded price of $2.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $4.2451 | $3.0242 | $4.9642 | +57.23% |
Intensity Therapeutics Inc Stock (INTS) Price Forecast for 2025
Intensity Therapeutics Inc Stock (INTS) is expected to reach an average price of $4.6586 in 2025, with a high prediction of $9.2792 and a low estimate of $0.0381. This indicates an +72.54% rise from the last recorded price of $2.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.9799 | $2.616 | $4.2321 | +10.37% |
| February, 2025 | $1.3379 | $1.2779 | $3.19 | -50.45% |
| March, 2025 | $0.7337 | $0.5337 | $2.5633 | -72.83% |
| April, 2025 | $0.1166 | $0.1994 | $1.0016 | -95.68% |
| May, 2025 | $4.7192 | $0.0441 | $9.2792 | +74.78% |
| June, 2025 | $5.4999 | $3.7272 | $8.5031 | +103.70% |
| July, 2025 | $2.7047 | $2.0368 | $5.7289 | +0.17% |
| August, 2025 | $1.7204 | $0.6627 | $2.7248 | -36.28% |
| September, 2025 | $3.4662 | $1.6444 | $3.9883 | +28.38% |
| October, 2025 | $2.071 | $1.682 | $3.5702 | -23.30% |
| November, 2025 | $1.0959 | $0.7859 | $2.253 | -59.41% |
| December, 2025 | $0.4095 | $0.0381 | $1.4668 | -84.83% |
Intensity Therapeutics Inc Stock (INTS) Price Forecast for 2026
The predicted value for Intensity Therapeutics Inc (INTS) in 2026 is set at an average of $4.1647. Estimates vary from a peak of $8.1988 to a trough of $0.1307, indicating an +54.25% surge from the present price of $2.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.6258 | $0.4477 | $0.2186 | -76.82% |
| February, 2026 | $0.1122 | $0.8022 | $0.959 | -95.85% |
| March, 2026 | $5.3915 | $0.3412 | $8.1988 | +99.69% |
| April, 2026 | $1.8461 | $1.0052 | $5.6223 | -31.63% |
| May, 2026 | $0.1798 | $0.1402 | $2.027 | -93.34% |
| June, 2026 | $1.9034 | $0.1307 | $3.0125 | -29.50% |
| July, 2026 | $1.078 | $0.748 | $2.8943 | -60.07% |
| August, 2026 | $0.295 | $0.29 | $1.34 | -89.07% |
| September, 2026 | $0.6006 | $0.3921 | $0.6559 | -77.76% |
| October, 2026 | $1.439 | $1.5769 | $1.3548 | -46.70% |
| November, 2026 | $1.9269 | $2.0311 | $2.0603 | -28.63% |
| December, 2026 | $4.332 | $1.4217 | $7.1183 | +60.44% |
Intensity Therapeutics Inc Stock (INTS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Intensity Therapeutics Inc (INTS) is $3.0322, with a high forecast of $6.0379 and a low forecast of $0.0264. This indicates an +12.30% increase from the last price of $2.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4235 | $0.0264 | $4.5698 | -84.32% |
| February, 2027 | $1.0149 | $0.3715 | $1.0595 | -62.41% |
| March, 2027 | $0.9346 | $0.0967 | $2.0367 | -65.39% |
| April, 2027 | $0.8261 | $0.6482 | $1.9325 | -69.40% |
| May, 2027 | $0.5269 | $0.0698 | $0.984 | -80.49% |
| June, 2027 | $1.2856 | $0.895 | $1.4894 | -52.39% |
| July, 2027 | $2.6159 | $1.8357 | $2.491 | -3.11% |
| August, 2027 | $3.1817 | $2.7112 | $3.1617 | +17.84% |
| September, 2027 | $0.8376 | $0.5277 | $6.0379 | -68.98% |
| October, 2027 | $0.4229 | $0.5759 | $3.5173 | -84.34% |
| November, 2027 | $1.4535 | $0.4882 | $0.366 | -46.17% |
| December, 2027 | $0.4608 | $0.8792 | $1.7338 | -82.93% |
Intensity Therapeutics Inc Stock (INTS) Price Forecast for 2028
In 2028, Intensity Therapeutics Inc (INTS) is projected to reach an average price of $2.588, with a high projection of $4.9575 and a low estimate of $0.2184. This indicates an -4.15% fall from the last price of $2.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2397 | $0.2184 | $0.9706 | -91.12% |
| February, 2028 | $0.7003 | $0.2727 | $0.5851 | -74.06% |
| March, 2028 | $3.0145 | $0.7154 | $2.6535 | +11.65% |
| April, 2028 | $3.6573 | $2.9858 | $3.6272 | +35.45% |
| May, 2028 | $4.283 | $3.8335 | $4.263 | +58.63% |
| June, 2028 | $1.6193 | $0.5307 | $4.9575 | -40.02% |
| July, 2028 | $0.4233 | $0.2629 | $2.4647 | -84.32% |
| August, 2028 | $2.4642 | $1.5059 | $1.318 | -8.74% |
| September, 2028 | $1.9068 | $2.2868 | $2.7306 | -29.38% |
| October, 2028 | $0.5295 | $0.7121 | $0.3381 | -80.39% |
| November, 2028 | $1.6203 | $1.2137 | $1.5121 | -39.99% |
| December, 2028 | $4.5174 | $1.6285 | $3.2174 | +67.31% |
Intensity Therapeutics Inc Stock (INTS) Price Forecast for 2029
The 2029 price forecast for Intensity Therapeutics Inc Stock (INTS) is $3.2883 on average, with a high prediction of $6.4657 and a low estimate of $0.111. This represents an +21.79% increase from the previous price of $2.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.7935 | $4.136 | $4.7634 | +77.54% |
| February, 2029 | $5.6581 | $4.9557 | $4.9531 | +109.56% |
| March, 2029 | $0.6829 | $4.6629 | $5.3643 | -74.71% |
| April, 2029 | $0.2373 | $0.111 | $3.1359 | -91.21% |
| May, 2029 | $2.3837 | $1.4689 | $2.0437 | -11.72% |
| June, 2029 | $3.2284 | $3.6747 | $3.7273 | +19.57% |
| July, 2029 | $1.3432 | $2.1422 | $2.8146 | -50.25% |
| August, 2029 | $2.5642 | $1.667 | $2.4392 | -5.03% |
| September, 2029 | $4.7942 | $2.5416 | $4.0562 | +77.56% |
| October, 2029 | $6.1253 | $5.2861 | $4.9817 | +126.86% |
| November, 2029 | $6.2022 | $6.078 | $5.8996 | +129.71% |
| December, 2029 | $5.5491 | $6.2391 | $6.4657 | +105.52% |
Intensity Therapeutics Inc Stock (INTS) Price Forecast for 2030
Intensity Therapeutics Inc Stock (INTS) is expected to reach an average price of $4.3652 in 2030, with a high forecast of $7.567 and a low forecast of $1.1635. This signifies an +61.68% surge from the last price of $2.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8152 | $1.1635 | $2.7967 | -69.81% |
| February, 2030 | $3.2771 | $2.5144 | $3.0391 | +21.37% |
| March, 2030 | $4.804 | $3.5412 | $4.7241 | +77.93% |
| April, 2030 | $2.9409 | $3.6509 | $4.0768 | +8.92% |
| May, 2030 | $3.592 | $2.6219 | $2.752 | +33.04% |
| June, 2030 | $5.63 | $3.4546 | $5.105 | +108.52% |
| July, 2030 | $6.3512 | $6.2822 | $6.1457 | +135.23% |
| August, 2030 | $7.0502 | $7.2002 | $7.0357 | +161.12% |
| September, 2030 | $7.3987 | $7.6075 | $7.567 | +174.03% |
| October, 2030 | $0.9655 | $3.4414 | $6.4965 | -64.24% |
| November, 2030 | $4.7346 | $2.216 | $3.7605 | +75.35% |
| December, 2030 | $6.0335 | $4.5589 | $5.0535 | +123.46% |
0.93%
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):